Antimicrobial Agents and Chemotherapy, August 2001, p. 2381-2382, Vol. 45, No. 8
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.8.2381-2382.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Nonenzymatic Chloramphenicol Resistance Mediated by
IncC Plasmid R55 Is Encoded by a floR Gene Variant
Axel
Cloeckaert,*
Sylvie
Baucheron, and
Elisabeth
Chaslus-Dancla
Station de Pathologie Aviaire et
Parasitologie, Institut National de la Recherche Agronomique, 37380 Nouzilly, France
Received 23 January 2001/Returned for modification 6 April
2001/Accepted 3 May 2001
 |
ABSTRACT |
The IncC plasmid R55, initially described in the 1970s and isolated
from Klebsiella pneumoniae, confers
nonenzymatic chloramphenicol resistance. The gene coding for
this resistance was cloned and sequenced and shows 95 to 97% nucleotide identity with the recently reported
floR gene from Salmonella enterica serovar
Typhimurium DT104 and from Escherichia coli animal
isolates, respectively, conferring cross-resistance to florfenicol.
 |
TEXT |
Resistance to chloramphenicol (CHL)
has been reported to be mainly due to the production of inactivating
enzymes, the CHL acetyl transferases (CATs) (11).
Nonenzymatic CHL resistance, however, was described in the late 1970s
and early 1980s for plasmids of different incompatibility groups from
gram-negative bacteria, such as the IncP-1 plasmid R26 from
Pseudomonas aeruginosa and the IncC plasmid R55 from
Klebsiella pneumoniae (10, 11). The
cml gene of plasmid R26 conferring nonenzymatic CHL
resistance was reported in 1986 by Dorman et al. (9) and
codes for a putative efflux pump related to the more recently described
CmlA protein of the P. aeruginosa In4 integron of
transposon Tn1696 (3). Nonenzymatic CHL
resistance has gained importance with the spread of multidrug-resistant
Salmonella enterica serovar Typhimurium DT104 world-wide
epidemic strains, which harbor on their chromosome an antibiotic
resistance gene cluster comprising a nonenzymatic CHL resistance gene
conferring cross-resistance to florfenicol (FFC) (1, 2, 4,
5).
FFC is a fluorinated analog of CHL approved in Europe for use against
pasteurellosis in cattle since January 1995. Previous studies have
shown that FFC is active against CHL-resistant strains producing either
CATs (6) or nonenzymatic CHL resistance mediated by the
CmlA efflux pump (3). The gene conferring cross-resistance to FFC has been named floR, floSt, flo, or
cmlA-like (1, 2, 4, 5, 15) and is closely
related (97% identity) to the pp-flo gene described in 1996 from a transferable R plasmid of the fish pathogen Pasteurella
piscicida (13), recently renamed Photobacterium
damselae subsp. piscicida. Their deduced amino acid
sequences show about 47% identity to that of the CmlA protein. All of
the gene products are assumed to belong to the 12 transmembrane segments family of export proteins of the major facilitator superfamily reviewed by Paulsen et al. (14). FFC resistance conferred
by the floR gene has also recently been reported in
Escherichia coli strains isolated from cattle and poultry
(7, 12, 15) and in S. enterica serovar Agona
strains isolated from poultry (8).
In the present study we analyzed nonenzymatic CHL resistance, with
particular attention to possible FFC cross-resistance, conferred by the
IncC plasmid R55 (150 kb; Tra+ Ap Cm Gm Su), among the
first to have been described as conferring nonenzymatic CHL resistance
in the 1970s (10, 11). Interestingly, this plasmid,
isolated from K. pneumoniae, has been reported to encode
enzymatic CHL resistance as well, namely, a type I CAT (11).
R55 FFC resistance and detection of the floR gene.
E. coli strain K-12 BM14 (pro met azi) carrying
plasmid R55 was verified as FFC resistant. Antibiograms and
the MICs of FFC were determined as described previously (1,
2). FFC disks and the drug itself were purchased from
Schering-Plough Animal Health (Kenilworth, N.J.). E. coli BM14 carrying plasmid R55 showed resistance to FFC
(MIC, 32 µg/ml) to the same extent as S. enterica serovars Typhimurium DT104 and Agona (8)
and previously described E. coli strains (7).
PCR was performed on the extracted plasmid DNA using internal
primers of the floR gene, cml01 and cml15, as
described previously (1, 2, 8). An amplification fragment of the expected size (496 bp) was obtained (data not shown). Nucleotide sequencing of the fragment revealed 95% identity with the
floR nucleotide sequence of S. enterica serovar
Typhimurium DT104 (data not shown), thus indicating that plasmid R55
carries a floR gene variant conferring resistance to FFC.
Southern blot hybridization of plasmid R55 digested by SacI,
BamHI, and BglI using a floR probe produced and labeled as described previously (1,
2, 7, 8) revealed bands of 12, 6, and 3 kb, respectively (not shown), and thus confirmed the presence of a floR gene
variant on this plasmid.
R55 floR gene variant and flanking regions.
The
floR-carrying 6-kb BamHI fragment of plasmid R55
was cloned in plasmid pGEM-7Zf (Ampr) (Promega,
Charbonnieres, France) and sequenced. Briefly,
BamHI-digested fragments of plasmid R55 were ligated into
plasmid pGEM-7Zf. Competent E. coli JM109 cells were
transformed with the recombinant plasmids. Selection of transformants
was done using Luria-Bertani agar plates supplemented with ampicillin
(100 µg/ml) and FFC (10 µg/ml). Positive clones were confirmed by
floR PCR on the extracted plasmids. One pGEM-7Zf plasmid
clone carrying the 6-kb BamHI insert was kept and named
plasmid pSR511. The FFC and CHL MICs for E. coli JM109 carrying plasmid pSR511 were 32 and 128 µg/ml, respectively. Those for E. coli JM109 without the plasmid were 4 µg/ml for
both antibiotics. DNA sequencing of the insert was performed by
Génome Express (Grenoble, France).
Comparative sequence analysis showed that the R55 floR gene
variant was 95 and 97% identical to previously reported
floR genes of S. enterica serovar Typhimurium
DT104 and E. coli animal isolates, respectively
(data not shown). The deduced amino acid sequence of the R55
floR gene variant showed 97 and 98% identity to that of floR of S. enterica serovar
Typhimurium DT104 and E. coli, respectively. Amino
acid changes occured principally in the sixth transmembrane
segment of the protein (data not shown).